InBody Co.,Ltd Stock: price and insider trades · South Korea

InBody Co.,Ltd is a Health Care company. Its directors and officers file their transactions with DART (FSS). Over the twelve months to 5 November 2026, 11 filings were filed, from 6 insiders.

Purchases and sales both appear in the filings: 3 purchases (3 insiders) and 2 sales (2 insiders). The totals do not cover 5 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 2 senior executives and 1 major shareholder among the declarants.

With 11 filings in twelve months, the company is more active than the median of 7 filings across the 2,656 companies we follow on the same exchange. Our records for InBody Co.,Ltd go back to 2021, with 12 purchases and 4 sales on the open market in total.

The clock since the last published purchase (30 September 2026) now reads 40 days. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. The shorter that gap, the sooner other investors can see what insiders have done.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.